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Abstract: Background: the aims of the randomized clinical trial were (i) to verify the association between periodontal 
disease and C-reactive protein (CRP) and (ii) to evaluate a possible reduction of serum CRP levels after non-surgical 
periodontal treatment. 
Methods: Thirty-two subjects, 18 affected by chronic periodontitis, and 14 periodontally healthy patients, aged between 
21 and 65 (41± 13) were included. Clinical and radiographic examinations were used for each patient to obtain three 
dental indices that were used to evaluate severity of periodontal disease and changes after treatment. Periodontal 
patients were randomly assigned to one of two groups for different treatments: special oral hygiene instructions alone or 
in combination with scaling and root planing. Blood samples were taken for measurement of CRP levels and 
eritrosedimentation rate before and after treatment  
Results: a reduction of clinical index CPSS was observed for both groups of periodontal patients after treatment but 
there were no statistically significant differences for CRP and ESR at baseline and between baseline and re-
examination. Non statistically significant differences of CRP values between periodontal patients and healthy controls 
were found 
Conclusions: CRP values don’t seem to change after non-surgical treatment of periodontitis, even in presence of a 
reduction of clinical indices.  
Keywords: Periodontal disease, C-reactive protein, Inflammation, Nephelometric method. 
INTRODUCTION 
Several studies over the last years have shown a 
possible association between periodontal and 
cardiovascular diseases [1-6]. This can be due to 
common risk factors such as age, smoking, and 
diabetes. It can also be due to the action of Gram-
negative bacteria and their products which, in the case 
of periodontal inflammation, may spread through the 
circulation and reach organs like the heart. Finally, 
inflammatory mediators such as TNFα, IL-1, IL-6, IFN-γ 
and PGE 2 can reach the bloodstream from inflamed 
periodontal sites [7]. Of these mediators, IL-6, released 
by activated macrophages, induces production of C-
reactive Protein (CRP) by liver hepatocytes. CRP 
represents a marker of inflammation, normally present 
in small quantities, but it can increase dramatically 
within 72 hours following tissue injury. This protein can 
act as an opsonine, binding specific cell membrane 
components of microorganisms and stimulating the 
activation of complement fragments to enhance 
opsonization and elimination of bacteria. In addition,  
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CRP can interact with natural killer cells and 
monocytes and may increase their tumoricidal activity 
[8]. 
In many studies CRP appears to be a risk predictor 
for cardiac and cerebrovascular events [1, 2, 6, 9]. 
When associated with smoking, hypertension or high 
plasma cholesterol levels, it acts as a “risk multiplier”. 
Concentrations >3 mg/l seem to increase the risk of 
myocardial infarction or stroke within 8 years by three 
or four times, both in medically healthy subjects and in 
subjects with previous episodes [10-12]. 
Hence, the aims of our clinical trial were (i) to verify 
whether levels of C-reactive protein are different 
between subjects affected by periodontal disease and 
healthy subjects using a standard laboratory 
procedure, and (ii) to evaluate a potential reduction of 
serum CRP levels after two different kinds of non-
surgical periodontal therapies. 
MATERIALS AND METHODS 
In order to set the sample dimension, several 
studies were examined with the aim to detect a value of 
minimum difference between periodontal and healthy 
subjects (Table 1). On the basis of the similar 
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experimental design, the difference reported by 
Ebersole et al. (1997) of approximately 1 mg/dl 
between periodontal patients and controls was used, 
establishing an alpha error of 0,05 and a power of 0,80 
for the significance test, so the number of subjects 
enrolled was 14 for each group. 
The 42 initial subjects, 28 with chronic periodontal 
disease, and 14 periodontally healthy, were aged 
between 21 and 65 years. The subjects were enrolled 
by a single operator among the patients examined at 
the Department of Periodontology of the School of 
Dentistry, University of Bologna, Italy, between 
September 2003 and June 2004. 
The exclusion criteria comprised: coronary heart 
disease, myocardial infarction within the last 24 
months, systemic illnesses or infections, antibiotic 
treatment, use of aspirin or treatment with any 
medication known to affect the serum level of 
inflammatory markers in the preceding two months [4, 
9, 13]. 
The 28 periodontal patients were randomly 
assigned to two treatment subgroups and the allocation 
sequence was made by computer. However, 10 
subjects did not come back for periodontal revaluation, 
so the number of periodontal patients for our analyses 
was reduced to 10 for Group 1 and 8 for Group 2. 
However, no adverse effect motivated the dropouts 
apart an inadequate compliance to the scheduled 
treatment. Group I drop out rate was 29% (4\14) and 
43% in Group II (6\14); the difference of 14% is 
slightly higher than 10%, considered the 
acceptable drop out selective rate. Despite this 
reduction in numbers at the follow-up, no significant 
differences were observed in demographic, dental and 
clinical parameters. 
Group 1 (10 periodontitis subjects) had: a baseline 
periodontal examination; the collection of a blood 
sample for evaluation of eritrosedimentation rate (ESR) 
and CRP; special oral hygiene instructions named 
hygienic therapy (see Box 1); gross scaling (full 
mouth); 4 sessions of scaling and root planing (one for 
each quadrant); periodontal revaluation and collection 
of a second blood sample one month after the 
completion of treatment.  
Box 1: Special Oral Hygiene Instructions Named 
Hygienic Therapy 
Each subject was instructed in proper oral hygiene practices: 
Bass technique for brushing lingual and buccal surfaces 
Tip for cleaning crevices and to create space (when needed) for 
the interdental brush 
Interdental brush in interproximal areas 
Plaque disclosing agent at least once a week. 
 
Group 2 (8 periodontal patients) had: a baseline 
periodontal examination; the collection of a blood 
sample for evaluation of ESR and CRP; special oral 
hygiene instructions (hygienic therapy) as with group 1; 
Table 1:  Median Values Reported in Literature for CRP (mg/dl) in Periodontal Patients 
Authors Number of Patients (N) CRP 
40 periodontal patients 0,91 in periodontal patients; 
Ebersole et al. 1997 
35 controls 0,21 in controls. 
Beck et al. 2000 1550 patients with at least 10% of sites with probing depth ≥4 mm; 
0,41 in patients with at least 10% of sites with probing 
depth≥4mm ; 
9145 patients without pockets; 0,29 in patients without pockets; 
Slade et al. 2000 
1817 edentulous. 0,40 in edentulous patients. 
54 patients with generalized periodontitis; 0,15 in patients with generalized periodontitis; 
Loos et al. 2000 
43 controls. 0,09 in controls. 
0,11 at baseline in periodontal patients; 
Mattila et al.2002 35 with adult periodontitis. 
0,03 of median decrease after treatment: 
at baseline with periodontal patients; 
D’Aiuto et al. 2004 94 patients with severe generalized periodontitis 
0,05 of median decrease after treatment. 
0,40 at baseline in periodontal patients; 
Ide et al. 2004 23 patients with generalized periodontitis. 
0,37 after treatment. 
\CRP, C-reactive protein. 
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periodontal revaluation and collection of a second 
blood sample one month after the first. The aim of 
choosing different treatments was to verify if 
supragingival plaque control alone, obtained through 
hygienic therapy, could influence CRP levels. 
Group 3 (14 periodontally healthy subjects) received 
a periodontal visit to confirm the periodontal health and 
the collection of a blood sample for evaluation of ESR 
and CRP.  
Subjects of groups 1 and 2 underwent a radiological 
examination to obtain a radiographical status. Clinical 
and periodontal parameters were collected by an 
expert calibrated operator at baseline and at 
revaluation, without any blinding. The principles 
outlined in the Declaration Of Helsinki on clinical 
research involving human subjects were adhered to. All 
the research was conducted in accordance with Italian 
law. 
Dental Indices 
Clinical and radiographic examinations were used 
for each subject to obtain three dental indices that, 
singularly or partially associated, had already been 
used in previous epidemiological studies [9, 15, 16]. 
The indices were used to evaluate severity of 
periodontal disease and changes after treatment. 
Panoramic Tomography Score (PTS). This was 
obtained by the sum of radiolucent periapical lesions, 
third-degree carious lesions, vertical bone pockets, 
furcation lesions and pericoronitis. 
Clinical Periodontal Sum Score (CPSS). This 
represents the sum of the number of sites with probing 
pocket depth of 4 mm or greater, the number of 
gingival sites with bleeding after probing, the number of 
sites with visible suppuration after probing and the 
number of furcation lesions exceeding grade 1. 
Clinical and Radiographic Sum Score (CRSS). This 
was calculated by the sum of the number of 
radiographic vertical defects, the number of furcation 
lesions and the CPSS. 
Serum CRP Analysis 
Blood samples of each patient were analyzed at the 
Central Laboratory of Sant’Orsola Hospital, Bologna. 
Serum was separated using standard laboratory 
techniques and C-reactive Protein was quantified by 
latex-enhanced nephelometry using a fully automated 
Behring Nephelometer Analyzer System (Dade 
Behring). Samples of serum were mixed with latex 
particles coated with anti-C-reactive protein antibodies, 
forming antigen-antibody complexes. Light scattering, 
proportional to the concentration of the analyte in the 
sample, was measured by nephelometric procedure. C-
reactive protein concentrations in mg/dl were 
calculated with reference to a calibration curve. With 
this method the minimum detectable concentration of 
CRP was 0,3 mg/dl. 
STATISTICAL ANALYSIS 
Statistical analysis was performed using a computer 
statistical package (SPSS 11.0, SPSS Inc. 2001, 
Chicago IL). Levene statistic was used to verify the 
homoschedasticity of variance. The significance of 
differences of CRP and ESR between Groups 1, 2 
(periodontal subjects) and 3 (controls) was calculated 
using analysis of covariance, by taking age as a 
covariate because of the different mean age between 
periodontal and healthy subjects, or Kruskal – Wallis 
analysis. The significance of differences between 
periodontal subjects (Groups 1+2) and controls (Group 
3) was calculated with the Mann Whitney test or with 
the Student t-test. Subgroup analyses were carried out 
in order to verify internal comparability of each 
subgroup (pre-specified analyses). Finally, 95% 
confidence intervals were calculated. 
RESULTS 
Four patients of Group 1 and 6 patients of Group 2 
did not come back for periodontal revaluation, so the 
number of periodontal patients for our analyses was 
reduced to 10 for Group 1 and 8 for Group 2. 
Thirty-two subjects (53% males) completed the 
study. Participants were mostly non-smokers (75%). 
The two groups of periodontal subjects (groups 1 and 
2) displayed a similar median age of 44-48 years. 
Control subjects had a median age of 33±15 years 
(Table 2). No significant differences were observed in 
demographic, dental and clinical parameters after the 
loss of subjects at follow-up. 
Table 3 describes the subject population 
considering dental and clinical parameters. A reduction 
of clinical index CPSS at revaluation for periodontal 
patients was observed: the reduction was 34% for 
group 1 patients and 38% for group 2 patients. Non 
statistically significant differences between Groups 1 
and 2 (periodontal patients) were observed for clinical 
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index CPSS, radiographic index PTS, clinical and 
radiographic sum score CRSS and number of sites with 
probing pocket depth ≥ 4 mm.  
Table 4 shows the mean values of CRP and ESR 
among the three groups of subjects examined at 
baseline and at second examination. At baseline p was 
equal to 0.007 for ESR with a significant interaction 
group-age. All the other differences were not 
statistically significant. Even by grouping periodontal 
subjects (group1 + group2), no statistically significant 
differences were observed with the healthy control 
group (group3). No significant difference of CRP values 
between smokers and non-smokers was observed. 
No important side effects or adverse events were 
observed. 
DISCUSSION 
Several studies in the last years have shown a 
possible association between periodontal disease and 
ischaemic heart disease (IHD) [3, 10, 11, 16, 18-20]. 
This association may partially be explained considering 
common risk factors like high levels of serum lipids, 
inflammatory and haemostatic factors. However, this 
hypothesis has not been supported by all authors. 
Hujoel et al. (2001) [21] argued that while periodontitis 
may coexist with IHD, it does not necessarily imply an 
Table 2: Description of the Subject Population using Age (mean ± SD), Gender and Smoking Habits 
  Group 1 (n=10) 
Group 2 
(n=8) 
Group 3 
(n=14) 
Age  44±12 48±8 33±15 
males 4 (40%) 5 (63%) 8 (57%) 
Gender 
females 6 (60%) 3 (38%) 6 (43%) 
No 7 (70%) 7 (87%) 10 (71%) 
≤10/day 3 (30%) - 2 (14%) Smoker 
>10/day - 1 (13%) 2 (14%) 
 
Table 3: Description of Subject Population Considering Dental and Clinical Parameters (mean value ± SD) 
  Group 1 (n=10) 
Group 2 
(n=8) 
Group 3 
(n=14) 
Number of natural teeth  25±5 28±2 30±2 
Number of sites with probing pocket depth ≥ 4 mm  62±34 84±27 - 
Panoramic Tomography Score  10±6 9±2 - 
baseline 70±36 (47-93) 97±53 (59-135) - 
Clinical Periodontal Sum Score 
revaluation 46±33 (25-67) 60±33 (36-84) - 
Clinical and Radiographic Sum Score  77±35 100±52 - 
(95% confidence interval). 
Table 4: C-reactive Protein (mg/dl) and Eritro-Sedimentation Rate (mm/h) Values Among the Subject Population 
(mean ± SD) 
  Group 1 (n=10) 
Group 2 
(n=8) 
Group 3 
(n=14) 
baseline 0,34±0,13 (0,25-0,42) 0,32±0,01 (0,30-0,34) 0,32±0,01 (0,12-0,52) 
CRP 
revaluation 0,42±0,28 (0,24-0,60) 0,32±0,01 (0,30-0,34) - 
baseline 13,0±9,5 (7,0-19,0) 9,4±7,0 (4,4-14,4) 6,0±3,4 (4,2-7,8) 
ESR 
revaluation 10,9±10,0 (4,7-17,1) 5,9±3,9 (3,1-8,7)  
CRP, C-reactive protein; ESR, eritrosedimentation rate (95% confidence interval). 
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increased risk of myocardial infarction or stroke. In this 
case, periodontitis treatment would remove the risk of 
inducing coronary disease and completely edentulous 
subjects would have a reduced risk of IHD. Hujoel et al. 
found edentulous patients to have no lesser risk of 
developing coronary heart disease than periodontal 
patients [21]. 
Chong et al. (2000) [22] and Armitage (2000) [23], 
in a review of studies published in the last years, 
concluded that the association between periodontitis 
and IHD is not evident and that they could simply be 
parallel phenomena [24-28]. Seymour [29] and Beck et 
al. [27] concluded that, while many studies indicate a 
relationship between this two multifactorial disorders, a 
cause-effect relationship has not been demonstrated in 
any of them. However, several studies in the last years 
have shown that increased serum C-reactive Protein 
levels seem to be a risk predictor for coronary heart 
disease [1, 2, 5, 6, 9]. 
As shown in Table 1, in the National Health and 
Nutrition Estimates Survey III (NHANES III) reported by 
Slade et al. [30] and Beck et al. [31] the median value 
of CRP was 0,41 mg/dl for patients with more than 10% 
of sites with probing pocket depth ≥ 4mm, and 0,28 
mg/dl for healthy patients. Ebersole et al. [17] reported 
an even more evident difference between periodontal 
patients and controls: 0,91 mg/dl vs. 0,22 mg/dl. 
Instead, Loos et al. [21], Mattila et al. [9] and D’Aiuto et 
al. [32] observed much smaller values for both 
periodontal patients and controls.  
In the present study, at the baseline, median CRP 
values among periodontal patients were not as high as 
those reported by Ebersole et al. [17], but similar to 
those reported by Ide et al. [33] and to those of the 
NHANES III reported by Slade et al. [30] and Beck et 
al. [31] , where the same nephelometric method was 
used. With this method, the minimum detectable 
concentration of CRP was 0,3 mg/dl. The same 
nephelometric method was used in the NHANES III. 
The nephelometric method was also used in the 
studies of Ide et al. [33] and Loos et al. [21], but with a 
different ratio of reagent to serum in the samples, 
obtaining smaller minimum detectable concentrations 
of CRP: 0,02 mg/dl and 0,03 mg/dl respectively. 
Different methods were used in the studies of 
Montebugnoli et al. [16] and D’Aiuto et al. [32], with 
CRP minimum detectable values of 0,02 mg/dl. At the 
second examination group 1 showed an increase in the 
mean CRP value, in spite of a statistically significant 
reduction of clinical periodontal sum score. Even if this 
result is not statistically significant, it seems to indicate 
a trend completely opposite to the expected one. This 
could be explained by the presence of a single subject 
with a CRP value much bigger than the others (1,21 
mg/dl). The cause of this higher value is not clear, but it 
was probably due to non-periodontal unrecognized 
reasons. The absence of statistically significant 
differences among periodontal and healthy groups 
before and after the treatment could be explained by 
the use of the standard nephelometric method that 
does not appear sensitive enough for periodontal 
purposes.  
Smokers were included in our study, like in the 
studies of Ebersole et al. [17], Beck et al. [31] and 
Mattila et al. [9] Smoke is considered a factor able to 
alter CRP levels [10, 34, 35]. However in our study, as 
in the studies of Friedrikkson et al. [36] and Loos et al. 
[3], there was no statistical difference of CRP values 
between smokers and non-smokers. 
In a recent study of D’Aiuto et al. (2004) [32] on 94 
sistemically healthy subjects with severe generalized 
periodontitis, there was a median decrease of 0,05 
mg/dl of CRP 6 months after non-surgical therapy. This 
decrease was observed in subjects that presented less 
than 30% of residual pockets and less than 30% of 
residual bleeding sites. 
Mattila et al. [9] obtained a median decrease of 0,03 
mg/dl after mechanical therapy and, when indicated, 
the use of metronidazole (Table 4). On the contrary no 
statistically significant difference for CRP values is 
reported before and after mechanical treatment in the 
study of Ebersole et al. [17]. 
One month after completion of mechanical 
treatment we observed a reduction of sites with pd ≥4 
mm, bleeding after probing and visible suppuration in 
both group 1 and 2, with a consequent decrease of 
CPSS clinical index of 34% for patients of group 1 and 
38% for patients of group 2. The greater reduction in 
Group 2 patients, that were not treated with scaling and 
root planning, was unexpected but it could be 
explained by the small number of patients.  
Even though it is necessary to take into 
consideration the limited number of the subjects 
examined, the present study shows that (i) non-surgical 
therapy induces an improvement of clinical periodontal 
indices, even in subjects that were only instructed to 
correct plaque control. Moreover it appears evident that 
(ii) a standard nephelometric method is not sensitive 
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enough to detect difference in CRP values between 
periodontal and non-periodontal subjects.  
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